These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Dehydroepiandrosterone inhibits B16 mouse melanoma cell growth by induction of differentiation.
    Author: Kawai S, Yahata N, Nishida S, Nagai K, Mizushima Y.
    Journal: Anticancer Res; 1995; 15(2):427-31. PubMed ID: 7763017.
    Abstract:
    BACKGROUND: Low serum concentrations of dehydroepiandrosterone (DHEA) and its sulfate are associated with an increased incidence of various human malignancies. DHEA has chemopreventive and antiproliferative effects in experimental studies. Accordingly, the effects of DHEA on B16 mouse melanoma cells were studied. MATERIALS AND METHODS: The effects of DHEA on cell number and melanin production of the melanoma cells were measured. Specific DHEA receptor was detected by a cytosol binding assay. Protein kinase C (PKC) activity of the melanoma cells was detected by phosphorylation of PKC specific substrate. RESULTS: DHEA dose-dependently inhibited the growth of melanoma cells and enhanced melanin production, which indicated the induction of differentiation. There was a [3H]DHEA specific binding protein in the melanoma cell cytosol. Although DHEA did not promote the translocation of PKC from the cytosolic to the membrane fraction, the total PKC activity was upregulated by treatment with DHEA. CONCLUSIONS: DHEA inhibited the growth of B16 mouse melanoma cells by the induction of differentiation, possibly related to PKC upregulation mediated by DHEA receptor.
    [Abstract] [Full Text] [Related] [New Search]